These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7889394)

  • 1. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes.
    Sykulev Y; Brunmark A; Jackson M; Cohen RJ; Peterson PA; Eisen HN
    Immunity; 1994 Apr; 1(1):15-22. PubMed ID: 7889394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.
    Sykulev Y; Brunmark A; Tsomides TJ; Kageyama S; Jackson M; Peterson PA; Eisen HN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11487-91. PubMed ID: 7972089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
    Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
    J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate.
    Tian S; Maile R; Collins EJ; Frelinger JA
    J Immunol; 2007 Sep; 179(5):2952-60. PubMed ID: 17709510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytotoxic T lymphocyte clone can recognize the same naturally occurring self peptide in association with a self and nonself class I MHC protein.
    Dutz JP; Tsomides TJ; Kageyama S; Rasmussen MH; Eisen HN
    Mol Immunol; 1994 Sep; 31(13):967-75. PubMed ID: 8084337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.
    Maenaka K; Juji T; Nakayama T; Wyer JR; Gao GF; Maenaka T; Zaccai NR; Kikuchi A; Yabe T; Tokunaga K; Tadokoro K; Stuart DI; Jones EY; van der Merwe PA
    J Biol Chem; 1999 Oct; 274(40):28329-34. PubMed ID: 10497191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I.
    Rabinovich BA; Li J; Hurren R; Miller RG
    Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.
    Ge Q; Stone JD; Thompson MT; Cochran JR; Rushe M; Eisen HN; Chen J; Stern LJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13729-34. PubMed ID: 12374859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells.
    Lee PU; Kranz DM
    Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.
    Hemmer B; Pinilla C; Gran B; Vergelli M; Ling N; Conlon P; McFarland HF; Houghten R; Martin R
    J Immunol; 2000 Jan; 164(2):861-71. PubMed ID: 10623833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
    Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
    J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.